CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Role of eurasian economic commission in global clinical research and development

Author: 
Dr. Marina Komaroff
Subject Area: 
Health Sciences
Abstract: 

Background: Eurasian Economic Commission (EEC) was established in 2014 by Belarus, Kazakhstan, Russia, Armenia and Kyrgyzstanas a regulatory body of the Eurasian Economic Union (EAEU).EEC’s goal is to unite participated states under the uniformed regulations for the development, registration, production, and circulation of medical products.In 2016, the EEC created and released about 40 regulatory documents for medical drugs and devices and half are currently under revision. Rationale: The United States Food and Drug Administration (FDA), European Medicines Agency (EMA), Japanese Ministry of Health, Labor and Welfare (MHLW) and other international organizations constantly revise and update regulations and guidelines for development and registration of medical products. They admit that existing process is long, expensive, and contains multiple gaps that motivate to look aggressively for novel approaches in clinical research. Therefore, it is an interest to understand if recently formed EEC has developed innovative ways to build pharmaceutical industry in the EAEU. Objective: The aim of this paper is to understandif EEC’sprogression in building domestic pharmaceutical industry carries scientific values and novel approaches that can be sharedwith theother global players in the field of clinical research. Method: To review and evaluate EEC’s signed-off regulationsin terms of consistency with theworld-wide standards, and/or possession of innovative scientific approaches. Conclusion: The developed by EEC regulations are consistent with international industry in terms ofconduct and supervision of clinical trials. There is little progress regarding the discovery and development of new medical products, possiblybecause of lack of scientific and analytical background underlying committed clinical research. There is no intention ofaligning with the global movement towards developing innovative approaches in clinical research.The author proposed some thoughts about alternativesthat could have been considered to build up anadvanced pharmaceutical industryin the EAEU.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran